Literature DB >> 21697412

High-resolution CT of complications of idiopathic fibrotic lung disease.

C R Lloyd1, S L F Walsh, D M Hansell.   

Abstract

Idiopathic pulmonary fibrosis (IPF) has a more variable clinical course than has been traditionally recognised. Many patients will remain stable over time while others experience relatively rapid deterioration. The prognosis and clinical course of patients with other fibrosing lung diseases is also variable. A number of conditions may complicate the clinical course of the idiopathic fibrosing lung diseases, which results in morbidity and mortality, but also represents potentially treatable causes of worsening symptoms. Infection and malignancy have a long-recognised association with IPF while other conditions, particularly pulmonary hypertension and acute exacerbation of IPF, are being increasingly recognised in this patient population. Many of these patients have serial high-resolution CT (HRCT) examinations that may demonstrate one or more of these supervening conditions. In this article we review the more common conditions that may complicate the course of idiopathic fibrosing lung disease with an emphasis on the HRCT appearance, which the reporting radiologist should be aware of.

Entities:  

Mesh:

Year:  2011        PMID: 21697412      PMCID: PMC3473493          DOI: 10.1259/bjr/65090500

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  81 in total

Review 1.  Acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Robert Hyzy; Steven Huang; Jeffrey Myers; Kevin Flaherty; Fernando Martinez
Journal:  Chest       Date:  2007-11       Impact factor: 9.410

Review 2.  Acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Bethany B Moore; Kevin R Flaherty; Kevin K Brown; Robert J Kaner; Talmadge E King; Joseph A Lasky; James E Loyd; Imre Noth; Mitchell A Olman; Ganesh Raghu; Jesse Roman; Jay H Ryu; David A Zisman; Gary W Hunninghake; Thomas V Colby; Jim J Egan; David M Hansell; Takeshi Johkoh; Naftali Kaminski; Dong Soon Kim; Yasuhiro Kondoh; David A Lynch; Joachim Müller-Quernheim; Jeffrey L Myers; Andrew G Nicholson; Moisés Selman; Galen B Toews; Athol U Wells; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-06-21       Impact factor: 21.405

3.  Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Masanori Akira; Takenori Kozuka; Satoru Yamamoto; Mitsunori Sakatani
Journal:  Am J Respir Crit Care Med       Date:  2008-05-01       Impact factor: 21.405

4.  Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens.

Authors:  Sunghoon Park; Gee Young Suh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Kyung Soo Lee; Nam Yong Lee; Won-Jung Koh
Journal:  Respir Med       Date:  2007-11-09       Impact factor: 3.415

5.  High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Authors:  David A Zisman; Arun S Karlamangla; David J Ross; Michael P Keane; John A Belperio; Rajan Saggar; Joseph P Lynch; Abbas Ardehali; Jonathan Goldin
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

6.  The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK.

Authors:  Ivan Le Jeune; Jonathan Gribbin; Joe West; Chris Smith; Paul Cullinan; Richard Hubbard
Journal:  Respir Med       Date:  2007-09-17       Impact factor: 3.415

7.  Operative indications for lung cancer with idiopathic pulmonary fibrosis.

Authors:  K Kushibe; T Kawaguchi; M Takahama; M Kimura; T Tojo; S Taniguchi
Journal:  Thorac Cardiovasc Surg       Date:  2007-12       Impact factor: 1.827

8.  Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study.

Authors:  Shoji Kudoh; Harubumi Kato; Yutaka Nishiwaki; Masahiro Fukuoka; Kouichiro Nakata; Yukito Ichinose; Masahiro Tsuboi; Soichiro Yokota; Kazuhiko Nakagawa; Moritaka Suga; Haiyi Jiang; Yohji Itoh; Alison Armour; Claire Watkins; Tim Higenbottam; Fredrik Nyberg
Journal:  Am J Respir Crit Care Med       Date:  2008-03-12       Impact factor: 21.405

9.  Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant.

Authors:  A F Shorr; J L Wainright; C S Cors; C J Lettieri; S D Nathan
Journal:  Eur Respir J       Date:  2007-07-11       Impact factor: 16.671

10.  Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis.

Authors:  C E Daniels; E S Yi; J H Ryu
Journal:  Eur Respir J       Date:  2008-02-06       Impact factor: 16.671

View more
  6 in total

1.  Serum analysis of coagulation factors in IPF and NSIP.

Authors:  E Bargagli; C Madioni; N Bianchi; R M Refini; R Cappelli; P Rottoli
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

Review 2.  Characteristics and evaluation of acute exacerbations in chronic interstitial lung diseases.

Authors:  Corey D Kershaw; Kiran Batra; Jose R Torrealba; Lance S Terada
Journal:  Respir Med       Date:  2021-04-26       Impact factor: 4.582

3.  Application of clinico-radiologic-pathologic diagnosis of diffuse parenchymal lung diseases in children in China.

Authors:  Dan Xu; Zhimin Chen; Huizhong Chen; Rongyan Huang; Shunying Zhao; Xiuyun Liu; Chunju Zhou; Yun Peng; Xinyu Yuan; Jizhen Zou; Hailing Zhang; Deyu Zhao; Enmei Liu; Yuejie Zheng; Lili Zhong; Min Lu; Jirong Lu; Guangmin Nong
Journal:  PLoS One       Date:  2015-01-08       Impact factor: 3.240

4.  Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification.

Authors:  Monica Palermo; Francesco Tiralongo; Giulio Distefano; Ada Vancheri; Mauro Giuffrè; Fabio Pino; Pietro Valerio Foti; Gianluca Sambataro; Carlo Vancheri; Stefano Palmucci; Antonio Basile
Journal:  Diagnostics (Basel)       Date:  2021-01-12

5.  Highlights of HRCT imaging in IPF.

Authors:  N Sverzellati
Journal:  Respir Res       Date:  2013-04-16

Review 6.  Imaging Review of the Lung Parenchymal Complications in Patients with IPF.

Authors:  Elisa Baratella; Ilaria Fiorese; Cristina Marrocchio; Francesco Salton; Maria Assunta Cova
Journal:  Medicina (Kaunas)       Date:  2019-09-20       Impact factor: 2.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.